Arix Bioscience Plc Publication of Annual Report & Notice of AGM (9948K)
May 12 2022 - 2:02AM
UK Regulatory
TIDMARIX
RNS Number : 9948K
Arix Bioscience Plc
12 May 2022
12 May 2022
ARIX BIOSCIENCE PLC (the "Company")
Publication of Annual Report and Notice of Annual General
Meeting
Further to the Company's 2021 Annual Financial Results
announcement issued on 5 May 2022, Arix Bioscience Plc, announces
that it has today published the Annual Report and Accounts (the
"Annual Report") for the financial year ended 31 December 2021
together with its Notice of 2022 Annual General Meeting (the
"AGM").
The Company hereby confirms that its Annual General Meeting will
be held on Tuesday 7 June 2022 at 11:00 (BST) at the offices of
Brown Rudnick LLP, 8 Clifford Street, London, W1S 2LQ, United
Kingdom.
The following documents have today been posted or otherwise made
available to shareholders by the Company:
1. Form of Proxy
2. Notice of 2022 Annual General Meeting
3. Annual Report and Accounts 2021
The Form of Proxy is publicly available on the Company's
website:
https://arixbioscience.com/investor-relations/document-library
The Annual Report and Notice of AGM is also publicly available
on the Company's website:
https://arixbioscience.com/investor-relations/document-library
Copies of the above documents have been submitted to the UK
National Storage Mechanism. The documents will therefore shortly be
available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism and at the
following address:
Arix Bioscience Plc
Duke Street House,
50 Duke Street,
London,
W1K 6JL,
United Kingdom
Enquiries:
Email: ir@arixbioscience.com
LEI: 213800OVT3AHQCXNIX43
Registrar and Receiving Agent: Equiniti Limited - 0371 384 2030
or +44 121 415 7047
Company Secretary: Kin Company Secretarial Limited - +44 20 8819
6486
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOASFLFLSEESEDI
(END) Dow Jones Newswires
May 12, 2022 02:02 ET (06:02 GMT)
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Apr 2024 to May 2024
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From May 2023 to May 2024